Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-24-001995 General Corporate
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.96% · OPTIONAL · VALID
Operating cash generation 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-335.37% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
197.55% · CORE · VALID
Inventory pressure 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
26.81% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
8.91% · CORE · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-471.66% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
131.80% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.97%
Current 1.96%
Delta 0.99% Cash Generation Decreased
Previous -313.10%
Current -335.37%
Delta -22.27% Growth Decreased
Previous 424.90%
Current 197.55%
Delta -227.34% Inventory Pressure Decreased
Previous 94.22%
Current 26.81%
Delta -67.41% Margin Decreased
Previous 36.74%
Current 8.91%
Delta -27.83% Profitability Decreased
Previous -323.62%
Current -471.66%
Delta -148.04% R And D Intensity Increased
Previous 96.07%
Current 131.80%
Delta 35.73% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.